In this study, primaquine, a malaria drug, was found to induce early endosome damage and reduce nEGFR; primaquine was also found to induce apoptosis levels in breast cancer through nEGFR/Stat3-dependent c-Myc downregulation. This evidence concerns the gene MYC and breast cancer.